Physician
Ar Texas Pediatrics, PLLC
Ar Texas Pediatrics, PLLC was paid $1.74M by Medicaid between Jul 2018 and May 2023, across 71 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 30% of everything it billed.
33Billing provider infoAR TEXAS PEDIATRICS, PLLC
HOUSTON, TX 77089
HOUSTON, TX 77089
33aNPI1619324969assigned 05/17/2016
33bProvider typePediatrics Physician
28Total paid$1.74M
24GClaims89,901
24DCodes billed71
24AFirst – last monthJul 2018 – May 2023
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#273 of 1,136
Median peer was paid$329K
This provider vs. median5.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12 | $560.88 | |
| 2019 | 108 | $4K | |
| 2020 | 9,758 | $124K | |
| 2021 | 32,449 | $617K | |
| 2022 | 35,835 | $757K | |
| 2023 | 11,739 | $240K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 10,186 | 8,329 | $514K |
| S8301 | Infection control supplies, not otherwise specified | 12% | 8,196 | 6,380 | $211K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 6.7% | 2,787 | 2,522 | $117K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 6.7% | 8,380 | 3,801 | $117K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.1% | 2,470 | 2,201 | $89K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.0% | 1,162 | 1,074 | $88K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 4.3% | 998 | 869 | $75K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.0% | 915 | 817 | $70K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.5% | 822 | 780 | $60K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.4% | 4,318 | 3,736 | $60K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.3% | 6,648 | 2,889 | $58K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.5% | 2,998 | 2,695 | $43K |
59 more codes
| 87634 | 2.3% | 667 | $39K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.2% | 483 | $39K |
| 99358 | Prolong nursin fac eval 15m | 2.2% | 736 | $39K |
| 99429 | 1.2% | 636 | $21K | |
| 97802 | 1.1% | 3,999 | $19K | |
| 99000 | <1% | 1,346 | $14K | |
| 99417 | Prolong home eval add 15m | <1% | 1,149 | $13K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 510 | $12K |
| 90461 | <1% | 1,654 | $10K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 864 | $7K |
| 92020 | <1% | 703 | $6K | |
| 92551 | <1% | 650 | $5K | |
| 99408 | <1% | 568 | $4K | |
| 81002 | <1% | 847 | $2K | |
| 99001 | <1% | 458 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 27 | $2K |
| 99072 | <1% | 432 | $2K | |
| 96160 | <1% | 637 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 89 | $1K |
| 99381 | <1% | 12 | $1K | |
| G2011 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes | <1% | 237 | $1K |
| 97169 | <1% | 40 | $448.80 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 15 | $191.58 |
| 90734 | <1% | 182 | $165.30 | |
| 99051 | <1% | 20 | $128.63 | |
| 96161 | <1% | 44 | $71.43 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 2,067 | $30.00 |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | <1% | 133 | $20.59 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 26 | $10.07 |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 15 | $4.89 |
| 90686 | <1% | 779 | $0.22 | |
| 90620 | <1% | 430 | $0.13 | |
| 90671 | <1% | 39 | $0.12 | |
| 90651 | <1% | 201 | $0.10 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 2,432 | $0.10 |
| 90710 | <1% | 335 | $0.02 | |
| 4037F | <1% | 1,185 | $0.01 | |
| 90670 | <1% | 723 | $0.01 | |
| 90685 | <1% | 423 | $0.01 | |
| 96127 | 0% | 581 | $0.00 | |
| G8711 | Prescribed antibiotic on or within 3 days after the episode date | 0% | 475 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 1,242 | $0.00 |
| 90723 | 0% | 258 | $0.00 | |
| 36416 | 0% | 601 | $0.00 | |
| 90680 | 0% | 199 | $0.00 | |
| 90696 | 0% | 57 | $0.00 | |
| 90698 | 0% | 16 | $0.00 | |
| 99070 | 0% | 136 | $0.00 | |
| G8712 | Antibiotic not prescribed or dispensed | 0% | 3,663 | $0.00 |
| 99415 | Prolong outpt/office vis | 0% | 126 | $0.00 |
| 1033F | 0% | 3,637 | $0.00 | |
| 90648 | 0% | 561 | $0.00 | |
| 99173 | 0% | 785 | $0.00 | |
| 90633 | 0% | 297 | $0.00 | |
| 4035F | 0% | 622 | $0.00 | |
| G0270 | Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes | 0% | 903 | $0.00 |
| 99401 | 0% | 36 | $0.00 | |
| 90715 | 0% | 20 | $0.00 | |
| 90681 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRAOSHAN, ASEEMA (MD/CEO)